Senior Clinical Trial Physician, Rheumatology at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Medical expertise in rheumatologic/autoimmune indications (lupus, scleroderma, inflammatory myositis, rheumatoid arthritis)
Ability to work closely with hematology/oncology physicians on CAR-T cell therapy in autoimmune disease context
Experience managing Phase 2 to Phase 3 clinical studies with demonstrated decision-making capabilities
Capability for matrix management across internal and external networks
Strategic insights into clinical development plans, biology, translational elements, and benefit-risk assessments

Responsibilities

Serves as primary source of medical accountability and oversight for multiple clinical trials or a single complex trial in rheumatologic/autoimmune indications
Supervises development, monitoring, analysis, and interpretation of clinical trials and clinical components of regulatory filings
Contributes to overall Therapeutic Area disease strategy and portfolio view
Provides strategic insights into clinical development plans
Provides medical and scientific expertise to cross-functional BMS colleagues
Manages Phase 2 to Phase 3 clinical studies
Participates in disease/indication strategy teams
Works with Research, Early and Late Development teams to support ID 4/5 and POC transitions
Supports cross-portfolio activities, including Protocol Review Committee, Business Development, and Quality/Compliance leadership

Skills

Clinical Trials

Rheumatology

CAR-T Cell Therapy

Autoimmune Diseases

Lupus

Scleroderma

Inflammatory Myositis

Rheumatoid Arthritis

Clinical Development

Benefit Risk Assessment

Protocol Review

Translational Medicine

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free